Relief Cardiovascular is developing the Relief System, a novel transcatheter smart implant designed to improve long-term outcomes in diuretic-resistant heart failure (DRHF). DRHF impacts millions of patients globally, with significantly elevated rates of mortality and rehospitalization due to persistent and worsening congestion. To address this, the Relief System incorporates autonomous renal vein pressure monitoring paired with a flow-modulating implant to enhance renal perfusion and diuretic efficiency to reduce congestion in DRHF patients.
Go to website: https://www.reliefcardio.com